Kestra Medical Technologies Ltd. (KMTS)
24.43
-2.22
(-8.33%)
USD |
NASDAQ |
Jan 09, 16:00
24.90
+0.47
(+1.92%)
After-Hours: 20:00
Kestra Medical Technologies Research and Development Expense (Annual): 15.65M for April 30, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Bruker Corp. | 376.50M |
| Azenta, Inc. | 30.39M |
| Harvard Bioscience, Inc. | 10.41M |
| Precipio, Inc. | 1.30M |
| Bionano Genomics, Inc. | 24.80M |